Spots Global Cancer Trial Database for positron emission tomography (pet)
Every month we try and update this database with for positron emission tomography (pet) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Gallium-68 Citrate PET Used in Prostate Cancer | NCT02391025 | Prostatic Neopl... | Gallium-68 citr... Positron Emissi... | 18 Years - | University of California, San Francisco | |
| 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules | NCT02448225 | Lung Carcinoma Solitary Pulmon... Cigarette Smoki... | Computed Tomogr... Computed Tomogr... fluorodeoxygluc... Fluorine F 18 L... Laboratory Biom... Positron Emissi... Positron Emissi... | 40 Years - 80 Years | Vanderbilt-Ingram Cancer Center | |
| An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs | NCT00414570 | Pancreatic Canc... | [18]F-FLT PET s... | 18 Years - | AHS Cancer Control Alberta | |
| Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer | NCT00647140 | Thyroid Neoplas... Thyroid Carcino... Medullary Carci... | 18F-L-DOPA PET | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer | NCT00873275 | Colorectal Canc... | bevacizumab FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin ursodiol RNA analysis gene expression... polymerase chai... western blottin... immunohistochem... laboratory biom... pharmacological... positron emissi... | 18 Years - | City of Hope Medical Center | |
| 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules | NCT02448225 | Lung Carcinoma Solitary Pulmon... Cigarette Smoki... | Computed Tomogr... Computed Tomogr... fluorodeoxygluc... Fluorine F 18 L... Laboratory Biom... Positron Emissi... Positron Emissi... | 40 Years - 80 Years | Vanderbilt-Ingram Cancer Center | |
| Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer | NCT03463889 | Thyroid Gland C... | Gallium Ga 68-l... Magnetic Resona... Positron Emissi... | 18 Years - | University of California, San Francisco | |
| 68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment | NCT02673151 | Prostate Adenoc... PSA Failure Recurrent Prost... | Computed Tomogr... 68Ga-PSMA-11 Positron Emissi... | 18 Years - | Stanford University | |
| 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas | NCT02175745 | Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Childhood High-... Childhood High-... Childhood Low-g... Childhood Low-g... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... | 18F-fluoro-dihy... Positron emissi... Computed tomogr... Magnetic resona... | 16 Years - | Stanford University | |
| 68Ga-DOTATATE Neuroblastoma Imaging Pilot | NCT04559217 | Neuroblastoma | Radiopharmaceut... | - 21 Years | Centre de recherche du Centre hospitalier universitaire de Sherbrooke | |
| Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma | NCT03262389 | Multiple Myelom... | Fludeoxyglucose... Sodium Acetate ... Fludeoxyglucose... Sodium Acetate ... | 20 Years - | Mayo Clinic | |
| 18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer | NCT01993160 | Prostate Cancer | Fluorocholine (... PET scan Whole body MRI | 18 Years - 99 Years | University Health Network, Toronto | |
| 68Ga-DOTATATE Neuroblastoma Imaging Pilot | NCT04559217 | Neuroblastoma | Radiopharmaceut... | - 21 Years | Centre de recherche du Centre hospitalier universitaire de Sherbrooke | |
| 18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas | NCT04895631 | Hyperparathyroi... | 18F-Fluorocholi... Positron emissi... | 13 Years - | University of California, San Francisco | |
| Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors | NCT03109262 | Primary Maligna... | Computed Tomogr... Positron Emissi... 90-Yttrium (Y-9... Technetium 99mT... Single-photon e... | 18 Years - | Stanford University | |
| Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer | NCT00647140 | Thyroid Neoplas... Thyroid Carcino... Medullary Carci... | 18F-L-DOPA PET | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| 64Cu-GRIP B in Patients With Advanced Malignancies | NCT05888532 | Prostate Cancer Renal Cancer Urethral Cancer Advanced Solid ... Metastatic Cast... Solid Tumor, Ad... | Copper-64 label... Positron Emissi... | 18 Years - | University of California, San Francisco | |
| Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma | NCT03262389 | Multiple Myelom... | Fludeoxyglucose... Sodium Acetate ... Fludeoxyglucose... Sodium Acetate ... | 20 Years - | Mayo Clinic | |
| 68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery | NCT02678351 | Stage II Prosta... Stage III Prost... | 68Ga-PSMA-11 Magnetic resona... Positron Emissi... | 18 Years - | Stanford University | |
| 18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer | NCT02121600 | Prostate Cancer | [F-18]-FCH PET scan MRI scan | 18 Years - | Lawson Health Research Institute | |
| Study of 18F-Fluoro-PEG6-IPQA | NCT01320059 | Lung Cancer | 18F-PEG6-IPQA Positron emissi... | 18 Years - | M.D. Anderson Cancer Center | |
| Study of 18F-Fluoro-PEG6-IPQA | NCT01320059 | Lung Cancer | 18F-PEG6-IPQA Positron emissi... | 18 Years - | M.D. Anderson Cancer Center | |
| Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy | NCT05996432 | Head and Neck S... Brain Metastase... | Magnetic Resona... Positron Emissi... 18F-fluoromison... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Impact of Positron Emission Tomography Imaging Prior to Liver Resection for Colorectal Adenocarcinoma Metastases | NCT00265356 | Colorectal Canc... Liver Metastase... | PET diagnostic ... | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial) | NCT00895349 | Cervical Cancer Squamous Cell C... Adenosquamous C... Adenocarcinoma | CT Abdomen and ... CT Abdomen and ... | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules | NCT02448225 | Lung Carcinoma Solitary Pulmon... Cigarette Smoki... | Computed Tomogr... Computed Tomogr... fluorodeoxygluc... Fluorine F 18 L... Laboratory Biom... Positron Emissi... Positron Emissi... | 40 Years - 80 Years | Vanderbilt-Ingram Cancer Center | |
| Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms | NCT04044937 | Intracranial Ne... Low Grade Gliom... Recurrent Gliob... Recurrent World... Recurrent WHO G... | F-18 Fluoroethy... Positron Emissi... | 3 Years - | University of California, San Francisco | |
| Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer | NCT01937117 | Breast Cancer | Positron emissi... Trastuzumab Pertuzumab | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer | NCT04377152 | Prostate Cancer Prostate Prostate Adenoc... | 68Gallium-PSMA-... Positron Emissi... | 18 Years - | University of California, San Francisco | |
| Gallium-68 Citrate PET Used in Prostate Cancer | NCT02391025 | Prostatic Neopl... | Gallium-68 citr... Positron Emissi... | 18 Years - | University of California, San Francisco | |
| 68Ga-PSMA PET Imaging of Upper Metastatic Gastric Cancers to Determine Eligibility to Endoradiotherapy | NCT05214820 | Upper Digestive... | Radiopharmaceut... | 18 Years - | Centre de recherche du Centre hospitalier universitaire de Sherbrooke | |
| 18F-Fluorocholine for the Detection of Parathyroid Adenomas | NCT03764007 | Hyperparathyroi... | 18F-Fluorocholi... Positron Emissi... | 13 Years - | University of California, San Francisco | |
| 68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer | NCT04716725 | Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | 68Ga-PSMA-11 Positron Emissi... | 18 Years - | University of California, San Francisco | |
| Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy | NCT04904120 | Melanoma (Skin) Melanoma Stage ... Melanoma, Uveal Melanoma, Mucos... | [203Pb]VMT01 [68Ga]VMT02 | 18 Years - 89 Years | Perspective Therapeutics | |
| 68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer | NCT04716725 | Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... | 68Ga-PSMA-11 Positron Emissi... | 18 Years - | University of California, San Francisco | |
| GA-68 DOTA-TOC of Somatostatin Positive Malignancies | NCT02177773 | Neuroendocrine ... Paraganglioma Carcinoid Tumor... Neuroblastoma | Computed Tomogr... Gallium Ga 68-E... Magnetic Resona... Positron Emissi... | 2 Years - | University of California, San Francisco | |
| Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy | NCT03493789 | Stage I Lung Ca... Stage I Non-Sma... Stage IA Non-Sm... Stage IB Non-Sm... Stage II Lung C... Stage II Non-Sm... Stage IIA Non-S... Stage IIB Non-S... | Fludeoxyglucose... Positron Emissi... Stereotactic Bo... | 18 Years - | Emory University | |
| Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial) | NCT00895349 | Cervical Cancer Squamous Cell C... Adenosquamous C... Adenocarcinoma | CT Abdomen and ... CT Abdomen and ... | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL | NCT05113576 | Diffuse Large B... | - | Second Affiliated Hospital, School of Medicine, Zhejiang University | ||
| Study of 18F-Fluoro-PEG6-IPQA | NCT01320059 | Lung Cancer | 18F-PEG6-IPQA Positron emissi... | 18 Years - | M.D. Anderson Cancer Center | |
| Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer | NCT03463889 | Thyroid Gland C... | Gallium Ga 68-l... Magnetic Resona... Positron Emissi... | 18 Years - | University of California, San Francisco | |
| Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy | NCT03493789 | Stage I Lung Ca... Stage I Non-Sma... Stage IA Non-Sm... Stage IB Non-Sm... Stage II Lung C... Stage II Non-Sm... Stage IIA Non-S... Stage IIB Non-S... | Fludeoxyglucose... Positron Emissi... Stereotactic Bo... | 18 Years - | Emory University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
